Skip to search formSkip to main contentSkip to account menu

Tozasertib

Known as: Cyclopropanecarboxamide, n-(4-((4-(4-methyl-1-piperazinyl)-6-((5-methyl-1h-pyrazol-3-yl)amino)-2-pyrimidinyl)thio)phenyl)-, n-(4-((4-(4-methylpiperazin-1-yl)-6-((5-methyl-1h-pyrazol-3-yl)amino)pyrimidin-2-yl)sulfanyl)phenyl)cyclopropanecarboxamide 
National Institutes of Health

Related topics

Related topics

3 relations
Aurora Kinase AAurora kinase inhibitor MK-0457

Broader (1)

VX680

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
New Kinase Inhibitors for the Treatment of Chronic Hematological Neoplasms-Editorial
Protein kinases (PKs) and lipid kinases (LKs) are good targets for signal transduction therapy, as these enzymes are involved in… 
2011
2011
Kinases A and B Vulnerability of Ewing ' s Sarcoma to Combined Inhibition of Aurora An Integrated Chemical Biology Approach Identifies Specific
Ewing’s sarcoma is a pediatric cancer of the bone that is characterized by the expression of the chimeric transcription factor… 
2010
2010
Gateways to clinical trials.
O(6)-Benzylguanine; (-)-Gossypol; Abatacept, AC-2592, Adalimumab, AIDSVAX gp120 B/E, Alemtuzumab, Aliskiren fumarate, ALVAC… 
2010
2010
Abstract 5422: Drug combination studies in a panel of 30 cell lines established from patient-derived tumor xenograft
In recent years, the focus of anticancer drug development has changed from conventional cytotoxic drugs to targeted agents…